X
AZN icon

Xponance’s AstraZeneca AZN Stock Holding History

Xponance’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
2,265
-632
-22% -$119K ﹤0.01% 1176
2026
Q1 		$571K Buy
2,897
+518
+22% +$99.9K ﹤0.01% 961
2025
Q4 		$437K Buy
2,379
+284
+14% +$49.8K ﹤0.01% 1006
2025
Q3 		$321K Buy
2,095
+327
+18% +$49.5K ﹤0.01% 1125
2025
Q2 		$247K Buy
1,768
+35
+2% +$4.91K ﹤0.01% 1227
2025
Q1 		$255K Buy
1,733
+112
+7% +$16.2K ﹤0.01% 1155
2024
Q4 		$212K Buy
1,621
+105
+7% +$14.7K ﹤0.01% 1275
2024
Q3 		$236K Buy
+1,516
New +$245K ﹤0.01% 1168
2020
Q2 		– Sell
-3,376
Closed -$604K – 1034
2020
Q1 		$604K Buy
+3,376
New +$318K 0.49% 46

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Xponance's AZN Position: Q2 2026 in Review

Xponance reduced its AstraZeneca (AZN) stake by 22% in Q2 2026, selling an estimated $119K and leaving 2,265 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Xponance first reported a position in AZN in Q1 2020 and has held it in 9 quarters since. The position peaked at $604K in Q1 2020. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Xponance held 2,265 shares of AstraZeneca worth $429K as of Q2 2026.
  • Xponance sold 632 AstraZeneca shares in Q2 2026, an estimated $119K.
  • AstraZeneca made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1176 holding.
  • Xponance first reported a position in AstraZeneca in Q1 2020 and has held it in 9 quarters since.
  • Xponance's AstraZeneca position peaked at $604K in Q1 2020.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.